NeoGenomics Inc

NEO.US
Healthcare · Diagnostics & Research
13.40
+0.26 (+1.98%)
USD · NASDAQ

Company Information

Company Name
NeoGenomics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US64049M2098
CIK: 0001077183
CUSIP: 64049M209
Currency: USD
Full Time Employees: 2,500
Phone: 239 768 0600
Fiscal Year End: December
IPO Date: Nov 02, 1999
Description:

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Address:

9490 NeoGenomics Way, Fort Myers, FL, United States, 33912

People

Directors & Officers

Name Title Year Born
Mr. Anthony P. Zook CEO & Director 1961
Mr. Warren Stone President & COO 1973
Ms. Elizabeth A. Floegel Chief Digital & Information Officer 1976
Ms. Alicia C. Olivo Executive VP of Business Development, General Counsel & Corporate Secretary 1984
Mr. Gary Passman Chief People & Culture Officer NA
Mr. Abhishek Jain Executive VP & CFO 1976
Mr. Gregory D. Aunan Senior VP & Chief Accounting Officer 1969
Ms. Kendra Sweeney Vice President of Investor Relations & Communications NA
Mr. Clarence Cooper Esq. Vice President of Compliance & Privacy NA
Dr. Andrew A. Lukowiak Ph.D. Chief Innovation Officer 1972

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 20, 2026 Warren Stone N/A Sale 22.13K $12.50 $276.60K
Nov 25, 2025 Alicia C Olivo N/A Sale 20.92K $12.00 $250.99K
May 27, 2025 Michael Aaron Kelly N/A Purchase 5.00K $7.60 $38.00K
May 12, 2025 Warren Stone N/A Purchase 5.70K $8.58 $48.91K
May 09, 2025 Lynn A Tetrault N/A Purchase 7.00K $8.14 $56.98K
May 07, 2025 Stephen M Kanovsky N/A Purchase 4.00K $7.78 $31.12K
May 07, 2025 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $8.00 N/A
May 06, 2025 Anthony P Zook N/A Purchase 18.90K $7.88 $148.93K
May 05, 2025 David Brian Perez N/A Purchase 10.00K $7.63 $76.30K
May 02, 2025 Jeffrey Scott Sherman N/A Purchase 20.00K $7.51 $150.20K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 19.96M Mar 31, 2026 15.33% $0.00 2.55%
Vanguard Group Inc 13.83M Dec 31, 2025 10.62% $0.00 -0.54%
First Light Asset Management, LLC 9.73M Mar 31, 2026 7.47% $6.47 -3.04%
Greenhouse Funds LLLP 9.10M Mar 31, 2026 6.99% $3.02 5.28%
Vanguard Portfolio Management, LLC 7.62M Mar 31, 2026 5.85% $0.00 0.00%
First Trust Advisors L.P. 6.16M Mar 31, 2026 4.73% $0.03 0.00%
Vanguard Capital Management, LLC 5.66M Mar 31, 2026 4.34% $0.00 0.00%
BRAIDWELL LP 5.62M Mar 31, 2026 4.31% $1.39 21.25%
State Street Corp 5.12M Mar 31, 2026 3.93% $0.00 2.84%
D. E. Shaw & Co LP 4.16M Mar 31, 2026 3.20% $0.02 -21.39%
Schroder Investment Management Group 3.57M Mar 31, 2026 2.74% $0.02 -11.18%
Delaware Management Holdings Inc 3.45M Mar 31, 2026 2.65% $0.04 -12.35%
Geode Capital Management, LLC 3.23M Mar 31, 2026 2.48% $0.00 1.71%
Bank of America Corp 3.05M Mar 31, 2026 2.35% $0.00 126.62%
Dimensional Fund Advisors, Inc. 2.67M Mar 31, 2026 2.05% $0.00 9.21%
Samlyn Capital, LLC 2.56M Mar 31, 2026 1.96% $0.32 84.22%
American Capital Management Inc 2.25M Mar 31, 2026 1.73% $0.90 -3.16%
Millennium Management LLC 2.22M Mar 31, 2026 1.71% $0.01 -57.29%
GW&K Investment Management, LLC 2.19M Mar 31, 2026 1.68% $0.14 -2.14%
Morgan Stanley - Brokerage Accounts 2.16M Mar 31, 2026 1.66% $0.00 1.73%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 First Trust NYSE Arca Biotech ETF 9.87M 7.58% ▼ 1.73% Jun 30, 2026
2 iShares Core S&P Small-Cap ETF 7.85M 6.03% ▲ 0.02% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 4.14M 3.18% ▲ 1.52% Jun 30, 2026
4 Nomura US Small Cap Core Equity 4.08M 3.13% ▲ 49.34% Jun 30, 2026
5 iShares Russell 2000 ETF 3.43M 2.63% ▲ 0.60% Jun 30, 2026
6 Vanguard Small Cap Index 2.99M 2.30% ▲ 0.15% Jun 30, 2026
7 Nomura Small Cap Core I 2.65M 2.03% ▼ 0.82% May 31, 2026
8 Vanguard Small Cap Growth Index Inv 1.73M 1.33% ▲ 2.75% Jun 30, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 1.49M 1.15% ▲ 1.79% Jun 30, 2026
10 Glenmede Small Cap Equity 1.38M 1.06% ▲ 19.52% Jun 30, 2026

Financial Highlights

Market Cap: $1.71B
EBITDA: $4.27M
PEG Ratio: $2.09
Book Value: $6.39
Earnings/Share: $-0.77
Profit Margin: -13.30%
Operating Margin: -9.34%
ROA (TTM): -2.64%
ROE (TTM): -11.56%
Revenue (TTM): $745.97M
Revenue/Share (TTM): $5.80
Earnings Growth (YOY): 130.60%
Revenue Growth (YOY): 11.10%

Valuation Metrics

Enterprise Value: $2.07B
Trailing P/E: 0.00
Forward P/E: 222.22

Shares Statistics

Shares Outstanding: 130.21M
Shares Float: 118.27M
% Insiders: 205.40%
% Institutions: 10,847.40%
Short % Float: 12.44%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$727.33M
Cost of Goods Sold
adjust
$-444.79M
Gross Profit
subtotal
$282.54M
SG&A
adjust
$-273.34M
R&D
adjust
$-37.08M
Other Operating Expense
adjust
$-38.21M
Operating Income
subtotal
$-66.08M
Other / Non-Operating Items
adjust
$-41.95M
Net Income
subtotal
$-108.03M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NEO.US!